SCHEMBL7315804

SCHEMBL7315804

Clc1cc(CCc2ccccn2)c2oc(-c3ccno3)nc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CCR2 P41597 3/20 0.34
MAPT P10636 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HSP90AA1 P07900 1/20 0.33
ADORA2A P29274 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325321 0.85 ADORA2A (0.49) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7322971 0.82 NPC1 (0.41) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7323231 0.80 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7317091 0.80 PDGFRB (0.38) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7324311 0.80 KDM4E (0.40) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7314123 0.80 KDM4E (0.37) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7315751 0.80 RAB9A (0.43) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7317490 0.79 KDM4E (0.40) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7318937 0.79 CHRNA7 (0.38) ALDH1A1KDM4ENPC1RAB9AHSD17B10
SCHEMBL7324755 0.79 ALDH1A1 (0.37) ALDH1A1KDM4ENPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US claimed
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US disclosed